Patients' expectations of screening and preventive treatments
- PMID: 23149525
- PMCID: PMC3495922
- DOI: 10.1370/afm.1407
Patients' expectations of screening and preventive treatments
Abstract
Purpose: An informed decision to accept a health care intervention requires an understanding of its likely benefit. This study assessed participants' estimates of the benefit, as well as minimum acceptable benefit, of screening for breast and bowel cancer and medication to prevent hip fracture and cardiovascular disease.
Methods: Three general practitioners sent questionnaires to all registered patients aged 50 to 70 years. Patients agreeing to participate in the study were asked to estimate the number of events (fractures or deaths) prevented in a group of 5,000 patients undergoing each intervention over a period of 10 years, and to indicate the minimum number of events avoided by the intervention that they considered justified its use. The proportions of participants that overestimated each intervention's benefit were calculated, and univariate and multivariable analyses of predictors of response were performed.
Results: The participation rate was 36%: 977 patients were invited to participate in the study, and 354 returned a completed questionnaire. Participants overestimated the degree of benefit conferred by all interventions: 90% of participants overestimated the effect of breast cancer screening, 94% overestimated the effect of bowel cancer screening, 82% overestimated the effect of hip fracture preventive medication, and 69% overestimated the effect of preventive medication for cardiovascular disease. Estimates of minimum acceptable benefit were more conservative, but other than for cardiovascular disease mortality prevention, most respondents indicated a minimum benefit greater than these interventions achieve. A lower level of education was associated with higher estimates of minimum acceptable benefit for all interventions.
Conclusion: Patients overestimated the risk reduction achieved with 4 examples of screening and preventive medications. A lower level of education was associated with higher minimum benefit to justify intervention use. This tendency to overestimate benefits may affect patients' decisions to use such interventions, and practitioners should be aware of this tendency when discussing these interventions with patients.
Conflict of interest statement
Conflicts of interest: authors report none.
Similar articles
-
Medication effectiveness may not be the major reason for accepting cardiovascular preventive medication: a population-based survey.BMC Med Inform Decis Mak. 2012 Aug 9;12:89. doi: 10.1186/1472-6947-12-89. BMC Med Inform Decis Mak. 2012. PMID: 22873796 Free PMC article.
-
Patients' expectations of the benefits and harms of treatments, screening, and tests: a systematic review.JAMA Intern Med. 2015 Feb;175(2):274-86. doi: 10.1001/jamainternmed.2014.6016. JAMA Intern Med. 2015. PMID: 25531451 Review.
-
Different ways to describe the benefits of risk-reducing treatments: a randomized trial.Ann Intern Med. 2007 Jun 19;146(12):848-56. doi: 10.7326/0003-4819-146-12-200706190-00006. Ann Intern Med. 2007. PMID: 17577004 Clinical Trial.
-
Behavioral and Pharmacotherapy Weight Loss Interventions to Prevent Obesity-Related Morbidity and Mortality in Adults: An Updated Systematic Review for the U.S. Preventive Services Task Force [Internet].Rockville (MD): Agency for Healthcare Research and Quality (US); 2018 Sep. Report No.: 18-05239-EF-1. Rockville (MD): Agency for Healthcare Research and Quality (US); 2018 Sep. Report No.: 18-05239-EF-1. PMID: 30354042 Free Books & Documents. Review.
-
Health improvement and prevention study (HIPS) - evaluation of an intervention to prevent vascular disease in general practice.BMC Fam Pract. 2010 Aug 5;11:57. doi: 10.1186/1471-2296-11-57. BMC Fam Pract. 2010. PMID: 20687956 Free PMC article. Clinical Trial.
Cited by
-
Screening for the primary prevention of fragility fractures among adults aged 40 years and older in primary care: systematic reviews of the effects and acceptability of screening and treatment, and the accuracy of risk prediction tools.Syst Rev. 2023 Mar 21;12(1):51. doi: 10.1186/s13643-023-02181-w. Syst Rev. 2023. PMID: 36945065 Free PMC article.
-
Treatment thresholds and minimal clinically important effect sizes of antiosteoporotic medication-Survey among physicians and lay persons in Germany.PLoS One. 2022 Aug 11;17(8):e0272985. doi: 10.1371/journal.pone.0272985. eCollection 2022. PLoS One. 2022. PMID: 35951613 Free PMC article.
-
[Health Professionals expectations' about the benefit of regular Primary Care interventions].Aten Primaria. 2022 Apr;54(4):102235. doi: 10.1016/j.aprim.2021.102235. Epub 2022 Feb 3. Aten Primaria. 2022. PMID: 35124558 Free PMC article. Spanish.
-
Shared decision-making in urology and female pelvic floor medicine and reconstructive surgery.Nat Rev Urol. 2022 Mar;19(3):161-170. doi: 10.1038/s41585-021-00551-4. Epub 2021 Dec 20. Nat Rev Urol. 2022. PMID: 34931058 Review.
-
Expectations about check-up examinations among Swiss residents: A nationwide population-based cross-sectional survey.PLoS One. 2021 Jul 21;16(7):e0254700. doi: 10.1371/journal.pone.0254700. eCollection 2021. PLoS One. 2021. PMID: 34288961 Free PMC article.
References
-
- Cooper A, Nherera L, Calvert N, O'Flynn N, Turnbull N, Robson J, et al. Clinical Guidelines and Evidence Review for Lipid Modification: Cardiovascular Risk Assessment and the Primary and Secondary Prevention of Cardiovascular Disease. Londo: National Collaborating Centre for Primary Care and Royal College of General Practitioners. National Institue for Health and Clinical Excellence; 2008. www.nice.org.uk/nicemedia/live/11982/40742/40742.pdf
-
- Doran T, Fullwood C, Gravelle H, et al. Pay-for-performance programs in family practices in the United Kingdom. N Engl J Med. 2006;355(4):375-384 - PubMed
-
- Domenighetti G, D'Avanzo B, Egger M, Berrino F, Perneger T, Mosconi P, et al. Women's perception of the benefits of mammography screening: population-based survey in four countries. Int J Epidemiol. 2003;32(5):816-821 - PubMed
-
- Schwartz LM, Woloshin S, Fowler FJ, Welch HG. Enthusiasm for cancer screening in the United States. JAMA. 2004;291(1):71-78 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical